References
- Ho A, Pagliuca A P, Kenyon M, Parker J E, Mijovic A, Devereux S, Mufti G J. Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukaemia with multilineage dysplasia using fludarabine, busulphan and alemtuzumab (FBC) conditioning. Blood 2004; 104: 1616–1623
- Kordasti S Y, Ingram W, Hayden J, Darling D, Barber L, Afzali B, Lombardi G, Wlodarski M W, Maciejewski J P, Farzaneh F, Mufti G J. CD4 + CD25 high Foxp3+ regulatory T-cells in myelodysplastic syndrome (MDS). Blood 2007; 110: 847–850
- Lim Z, Killick S, Germing U, Cavenagh J, Culligan D, Bacigalupo A, Marsh J, Mufti G J. Low IPSS score and bone marrow hypocellularity in MDS patients predict hematological responses to antithymocyte globulin. Leukaemia 2007; 21: 1436–1441